LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads) on and off LinkedIn. Learn more in our Cookie Policy.

Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings.

Poolbeg Pharma plc’s Post

View organization page for Poolbeg Pharma plc, graphic

Poolbeg Pharma plc

2,985 followers

2w

As we close out another exciting year at Poolbeg Pharma plc, we we send our warmest holiday wishes to all of our followers, team members, investors and partners! 🎄 #MerryChristmas #POLB

1 Comment

To view or add a comment, sign in

More Relevant Posts

Vincent Lima

Managing Director at Moelis & Company
3w
Report this post
Moelis acts as Exclusive Financial Advisor to Ayrmid Pharma, the parent company of Gamida Cell Ltd., on its in-license of rights to APHEXDA®️ and concurrent investment by Highbridge Capital Management in BioLineRx. #DealAdvisory Press release: https://bit.ly/3OYltZ3
Like Comment
To view or add a comment, sign in
Roger Hoit

Managing Director / Chairman, Private Equity Solutions at Moelis & Company
3w
Report this post
Moelis acts as Exclusive Financial Advisor to Ayrmid Pharma, the parent company of Gamida Cell Ltd., on its in-license of rights to APHEXDA®️ and concurrent investment by Highbridge Capital Management in BioLineRx. #DealAdvisory Press release: https://bit.ly/4ghLizc
Like Comment
To view or add a comment, sign in
Will Peters

Managing Director at Moelis & Company
3w
Report this post
Moelis acts as Exclusive Financial Advisor to Ayrmid Pharma, the parent company of Gamida Cell Ltd., on its in-license of rights to APHEXDA®️ and concurrent investment by Highbridge Capital Management in BioLineRx. #DealAdvisory Press release: https://bit.ly/49CcshT
Like Comment
To view or add a comment, sign in
Dr. Timos Papagatsias

BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
8mo
Report this post
Thoughts on this? >> A once-public psychedelic biotech reemerges with $103M from MPM and Novo Holdings >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #pharmaceutical #biotech #healthcare

A once-public psychedelic biotech reemerges with $103M from MPM and Novo Holdings

https://endpts.com
Like Comment
To view or add a comment, sign in
Rich Harding

Managing Director, Head of US Private Equity Solutions & US Healthcare Services
3w
Report this post
Moelis acts as Exclusive Financial Advisor to Ayrmid Pharma, the parent company of Gamida Cell Ltd., on its in-license of rights to APHEXDA®️ and concurrent investment by Highbridge Capital Management in BioLineRx. #DealAdvisory Press release: https://bit.ly/4iFPRFm
Like Comment
To view or add a comment, sign in
Biotech feed

304 followers
1mo
Report this post
Sarepta rebuilds drug pipeline with Arrowhead deal A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 million in cash and another $325 million in equity investment.... https://lnkd.in/em5HYErT #BioTech #science

Sarepta rebuilds drug pipeline with Arrowhead deal

openexo.com
Like Comment
To view or add a comment, sign in
SNV Sudhir

Senior journalist | US state dept’s IVLP participant l AMPPP Co’ 23 @ Indian School of Business (ISB) | Cover politics, public policy & Industry in Telugu states Telangana & Andhra
1mo
Report this post
Hyderabad based Suven Pharmaceuticals Limited ("Suven"), a technology-leading CDMO specializing in complex and innovative drug modalities, has announced the acquisition of a controlling stake in NJ Bio Inc with an investment of $64.4 million. Read more at: https://lnkd.in/gAn46Kwp

Hyderabad's Suven to acquire controlling stake in Princeton based NJ Bio, Inc

deccanherald.com
Like Comment
To view or add a comment, sign in
Tyler M.

Managing Director at Moelis & Company
3w
Report this post
Moelis acts as Exclusive Financial Advisor to Ayrmid Pharma, the parent company of Gamida Cell Ltd., on its in-license of rights to APHEXDA®️ and concurrent investment by Highbridge Capital Management in BioLineRx. #DealAdvisory Press release: https://bit.ly/41I2oCd
Like Comment
To view or add a comment, sign in
Ramy Ibrahim

Managing Director at Moelis & Company
2w
Report this post
Moelis acts as Exclusive Financial Advisor to Ayrmid Pharma, the parent company of Gamida Cell Ltd., on its in-license of rights to APHEXDA®️ and concurrent investment by Highbridge Capital Management in BioLineRx. #DealAdvisory Press release: https://bit.ly/49NRzjG
Like Comment
To view or add a comment, sign in
Cliniminds Pharmacovigilance

Global Pharmacovigilance Training & Skills Institution and Consulting Practice. We make physicians, pharmacists, nurses & life sciences professionals employable. Also offer corporate pharmacovigilance training solutions.
5mo
Report this post
CLINIMINDS REVIEW Thank you, Vikrant Gavkar, for your invaluable review on Google; your support and feedback are greatly appreciated! #cliniminds #studentreview #clinimindsreview #studentsuccess #placementsupport #bsc #msc #bpharm #mpharm #pharmd #biotechnology #lifesciences #pharmd
Like Comment
To view or add a comment, sign in

Poolbeg Pharma plc

2,985 followers

View Profile Connect

More from this author

Explore topics